Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Appoints four industry experts
February 3, 2012
By: Tim Wright
Editor-in-Chief, Contract Pharma
PCI Synthesis, Inc. has appointed several experts following the completion of a major expansion of its Devens, MA R&D facility. The expansion includes several new research hoods, analytical instruments, additional support equipment, additional staff, and a major expansion to the site’s existing kilo lab capacity to support early- and late-stage clinical candidate programs. Elie Saikali, Ph.D., has been appointed director of manufacturing. Dr. Saikali oversees and directs all cGMP manufacturing operations, FDA and ICH guidelines. He joins the company from Lonza, Inc., where he held positions of increasing responsibility in process R&D, culminating with the position of product manager. Mehdi Yazdi, Ph.D., has been appointed director of Quality Control and Analytical Services. Dr. Yazdi is focused on improving PCI’s entire Quality Control and Analytical Development function. While at the company, he has been instrumental in revamping the entire department, including improving training, ensuring consistency, building an analytical development team that has improved outcomes. He joined the company from Clariant Life Science Molecules, where he served as QC Manager. Prior to that he was with DPT, responsible for the analytical development of large and small molecule finished dosage forms. Don Dickison has been appointed director of business development. Mr. Dickison is responsible for the day-to-day business development activities for fine and specialty chemicals including emerging pharma. His prior experience includes positions with PRS Pharma and Eli Lilly in various sales and sales management roles. Paul Nichols, Ph.D., has been appointed director of cGMP Kilo Lab. Dr. Nichols is responsible for early phase clinical drug substance development and manufacturing for clients. Dr. Nichols joins the company from Array BioPharma, where he served as senior research investigator. Prior to that, he worked at Abbott Labs as a research scientist.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !